We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+763.65%
AUM
$77.1B
AUM Growth
-$1.68B
(-2.1%)
Cap. Flow
-$2.68B
Cap. Flow
% of AUM
-3.48%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
3,716
New
704
Increased
979
Reduced
1,056
Closed
911
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.75% |
| 2 | Industrials | 9.36% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Healthcare | 7.75% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Liberty Broadband Class C
LBRDK
$4.88B
| $22.4M | 0.03% |
446,255
-493,344
| -53% | -$24.9M |
|
|
NBIS
602
PUT
Nebius Group N.V.
NBIS
$48.3B
| $22.3M | 0.03% |
215,400
-140,600
| -39% | -$14M |
|
603
Upstart Holdings
UPST
$2.63B
| $22.3M | 0.03% |
869,416
+849,704
| +4,311% | +$29.9M |
|
604
PUT
Verizon
VZ
$195B
| $22.3M | 0.03% |
443,400
+69,400
| +19% | +$3.22M |
|
605
GDS Holdings
GDS
$6.56B
| $22.2M | 0.03% |
550,485
+280,416
| +104% | +$12M |
|
606
Merit Medical Systems
MMSI
$5.07B
| $22.1M | 0.03% |
320,659
+187,221
| +140% | +$14.6M |
|
607
Group 1 Automotive
GPI
$3.41B
| $22M | 0.03% |
66,628
+57,971
| +670% | +$20.2M |
|
|
CTNM
608
Contineum Therapeutics
CTNM
$579M
| $22M | 0.03% |
1,685,635
-157,165
| -9% | -$2.11M |
|
609
The Greenbrier Companies
GBX
$1.52B
| $22M | 0.03% |
417,461
+74,103
| +22% | +$3.91M |
|
610
PUT
BP
BP
$116B
| $22M | 0.03% |
467,600
+28,000
| +6% | +$1.1M |
|
611
Brighthouse Financial
BHF
$3.56B
| $21.9M | 0.03% |
+365,131
| New | +$22.8M |
|
612
BILL Holdings
BILL
$4.49B
| $21.9M | 0.03% |
570,537
+61,330
| +12% | +$2.74M |
|
613
Jefferies Financial Group
JEF
$12.6B
| $21.8M | 0.03% |
528,584
+101,219
| +24% | +$5.25M |
|
|
NVO
614
PUT
Novo Nordisk
NVO
$208B
| $21.8M | 0.03% |
593,500
+516,500
| +671% | +$24.5M |
|
615
CALL
Broadcom
AVGO
$1.85T
| $21.8M | 0.03% |
70,300
-20,400
| -22% | -$6.71M |
|
616
United Therapeutics
UTHR
$25.8B
| $21.7M | 0.03% |
36,623
-19,311
| -35% | -$9.62M |
|
|
DRUG
617
Bright Minds Biosciences
DRUG
$719M
| $21.7M | 0.03% |
297,158
+71,746
| +32% | +$5.78M |
|
618
UGI
UGI
$7.74B
| $21.7M | 0.03% |
595,195
+461,945
| +347% | +$17.4M |
|
619
PUT
ASML
ASML
$626B
| $21.7M | 0.03% |
16,400
-16,100
| -50% | -$22.1M |
|
620
Roku
ROKU
$21.5B
| $21.6M | 0.03% |
228,587
-1,388,449
| -86% | -$135M |
|
621
PUT
Eli Lilly
LLY
$1.02T
| $21.6M | 0.03% |
23,500
+1,400
| +6% | +$1.42M |
|
622
Annexon
ANNX
$834M
| $21.5M | 0.03% |
3,886,909
+587,653
| +18% | +$3.31M |
|
623
Trip.com Group
TCOM
$29.6B
| $21.4M | 0.03% |
430,366
+368,688
| +598% | +$21.5M |
|
|
HTBK
624
DELISTED
Heritage Commerce
HTBK
| $21.3M | 0.03% |
1,707,998
+406,830
| +31% | +$5.17M |
|
625
PUT
Estee Lauder
EL
$30.4B
| $21.3M | 0.03% |
296,200
+226,900
| +327% | +$23.2M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Balyasny Asset Management held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Balyasny Asset Management withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Balyasny Asset Management opened a new position in Silicon Laboratories worth $257M.
- Balyasny Asset Management's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Balyasny Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Balyasny Asset Management's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Balyasny Asset Management fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Balyasny Asset Management's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Balyasny Asset Management opened 704 new positions and closed 911 in Q1 2026.
- Balyasny Asset Management's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.